Evidence map›Paper›PMID 42145704›Full record

ArticleBiomedical optics express2026

WeakMitoSAM: competitive prompt aggregation for point-supervised mitochondria segmentation in electron microscopy images.

Yuanwei Li, Xinliang Zhang, Hangzhou He, Kaiwen Li, Shuang Zeng, Chuqiao Yang, Lei Zhu, Yanye Lu

Abstract read
In one paragraph

Article in Biomedical optics express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yuanwei LiInstitute of Medical Technology, Peking University Health Science Center, Peking University, Beijing, China.
Xinliang ZhangInstitute of Medical Technology, Peking University Health Science Center, Peking University, Beijing, China.
Hangzhou HeDepartment of Biomedical Engineering, College of Future Technology, Peking University, Beijing, China.
Kaiwen LiInstitute of Medical Technology, Peking University Health Science Center, Peking University, Beijing, China.ORCID https://orcid.org/0000-0002-4988-2687
Shuang ZengDepartment of Biomedical Engineering, College of Future Technology, Peking University, Beijing, China.
Chuqiao YangInstitute of Medical Technology, Peking University Health Science Center, Peking University, Beijing, China.
Lei ZhuInstitute of Medical Technology, Peking University Health Science Center, Peking University, Beijing, China.
Yanye LuInstitute of Medical Technology, Peking University Health Science Center, Peking University, Beijing, China.ORCID https://orcid.org/0000-0002-3063-8051

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial morphology is a critical indicator of cellular metabolic status and disease pathogenesis, requiring high-resolution visualization and precise segmentation in electron microscopy (EM) images. While fully supervised deep learning models have achieved significant progress, their reliance on dense pixel-wise annotations presents a major bottleneck due to the labor-intensive labeling process and expert variability near the optical diffraction limit. Existing weakly supervised methods, primarily designed for densely packed instances, often fail to generalize to the sparse distribution of mitochondria in EM data. In this paper, we propose WeakMitoSAM, a novel weakly supervised framework for high-precision mitochondria segmentation using sparse point annotations. Our approach introduces the competitive aggregation of multiple prompts strategy, which employs a Bias-augmented Softmax mechanism to reconcile semantic ambiguities and suppress background noise, effectively converting sparse priors into high-fidelity pseudo-labels. Subsequently, segment anything model is specialized for mitochondrial ultrastructures via low-rank adaptation, ensuring parameter-efficient domain adaptation. Experimental results across four public EM datasets demonstrate that WeakMitoSAM achieves state-of-the-art performance in point-supervised scenarios and even outperforms several fully supervised benchmarks, providing an efficient and robust solution for large-scale mitochondrial morphofunctional analysis.

Identifiers

PMID42145704
PMCPMC13178590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.